BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26077553)

  • 1. Risk factors for primary sclerosing cholangitis.
    Boonstra K; de Vries EM; van Geloven N; van Erpecum KJ; Spanier M; Poen AC; van Nieuwkerk CM; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; Beuers U; Ponsioen CY;
    Liver Int; 2016 Jan; 36(1):84-91. PubMed ID: 26077553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.
    Mitchell SA; Thyssen M; Orchard TR; Jewell DP; Fleming KA; Chapman RW
    Gut; 2002 Oct; 51(4):567-73. PubMed ID: 12235082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior.
    van Erpecum KJ; Smits SJ; van de Meeberg PC; Linn FH; Wolfhagen FH; vanBerge-Henegouwen GP; Algra A
    Gastroenterology; 1996 May; 110(5):1503-6. PubMed ID: 8613056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.
    Florin TH; Pandeya N; Radford-Smith GL
    Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
    Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
    J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.
    Halliday JS; Djordjevic J; Lust M; Culver EL; Braden B; Travis SP; Chapman RW
    J Crohns Colitis; 2012 Mar; 6(2):174-81. PubMed ID: 22325171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.
    Park YE; Cheon JH; Park JJ; Kim YJ; Choi CH; Park Y; Park SJ; Kim TI; Kim WH
    Int J Colorectal Dis; 2018 Oct; 33(10):1497-1500. PubMed ID: 29987360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.
    Eaton JE; Juran BD; Atkinson EJ; Schlicht EM; Xie X; de Andrade M; Lammert CS; Luketic VA; Odin JA; Koteish AA; Kowdley KV; Chopra KB; Hirschfield GM; Chalasani NP; Lazaridis KN
    Aliment Pharmacol Ther; 2015 May; 41(10):980-90. PubMed ID: 25783671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.
    Saarinen S; Olerup O; Broomé U
    Am J Gastroenterol; 2000 Nov; 95(11):3195-9. PubMed ID: 11095341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
    Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
    Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
    Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
    Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.